Emerald Health Sciences Inc.'s Form 4 filing
Skye Bioscience, Inc. (SKYE) · filed Mar 17, 2023
- Accession no.
- 0001567619-23-005234
- Filed
- Mar 17, 2023, 2:52 PM ET
- Trade date
- Nov 10, 2022-Feb 22, 2023
- Filing delay
- 127 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 5 derivative transactions. It was filed 127 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Emerald Health Sciences Inc.CIK 0001728413 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2023 | Common Stock | AGrant or awardAcquired | +16,641,486 | $0.017 | +$282,905.26 | 128,028,737 | Direct | |
| Feb 22, 2023 | Common Stock | AGrant or awardAcquired | +41,379,164 | $0.0386 | +$1,597,235.73 | 169,407,901 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2022 | Common Stock | JOtherAcquired | +9,141,486 | $0.00 | $0 | 9,141,486 | Direct | |
| Feb 22, 2023 | Common Stock | DReturned to the companyDisposed | −9,141,486 | $0.00 | $0 | 0 | Direct | |
| Feb 22, 2023 | Common Stock | PPurchaseDisposed | −2,500,000 | $0.00 | $0 | 0 | Direct | |
| Feb 22, 2023 | Common Stock | DReturned to the companyDisposed | −2,500,000 | $0.00 | $0 | 0 | Direct | |
| Feb 22, 2023 | Common Stock | DReturned to the companyDisposed | −2,500,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.